Sofpironium
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Derivatization-Assisted Lipase-Mediated Separation of Optically Pure α-Cyclopentylmandelic Acid Through Enhanced Substrate Recognition.
Journal: Molecules (Basel, Switzerland)
Published: August 21, 2026
Sofpironium Bromide for the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: Cureus
Published: May 07, 2026
Post-marketing Safety Surveillance of Sofpironium Gel, 12.45%, A Novel Treatment for Primary Axillary Hyperhidrosis in Patients ≥9 Years.
Journal: Journal of the American Academy of Dermatology
Published: April 27, 2026
Efficacy and safety of topical sofpironium bromide in treating primary axillary hyperhidrosis: systematic review and meta-analysis of randomized controlled trials.
Journal: Dermatology reports
Published: March 09, 2026
Clinical Characteristics and Treatment Patterns of Hyperhidrosis in Northern Hokkaido: A Single-Center Retrospective Descriptive Study.
Journal: The Journal of dermatology
Published: February 09, 2026
Sofpironium Topical Gel Is Effective for Axillary Hyperhidrosis.
Journal: American family physician
Published: January 14, 2026
Efficacy and Safety of Topical Anticholinergics in the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-analysis.
Journal: Clinical drug investigation
Published: October 02, 2025
The Drug Update: Recent drug approvals, winter 2025 edition.
Journal: The Nurse practitioner
Published: January 23, 2025
Efficacy and safety of sofpironium in treatment of primary hyperhidrosis: a systematic review.
Journal: The Journal of dermatological treatment
Published: December 13, 2024
Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studies.
Journal: Journal of the American Academy of Dermatology
Published: October 09, 2024
Sofpironium (Sofdra) for primary axillary hyperhidrosis.
Journal: The Medical letter on drugs and therapeutics
Published: August 13, 2024
Last Updated: 11/08/2026